[Federal Register: September 23, 2003 (Volume 68, Number 184)]
[Notices]
[Page 55246]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23se03-23]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Notices of Approval of New Animal Drug Applications; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting two
documents that provided notice of the approval of new animal drug
applications (NADAs) and abbreviated new animal drug applications
(ANADAs). FDA is correcting the chemical entities listed in the subject
lines of both documents that were transposed during document
preparation. The address for one of the drug sponsors is also being
corrected. These corrections are being made to improve the accuracy of
the Federal Register.
FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for
Veterinary Medicine (HFV-6), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 301-827-4567, e-mail:
ghaibel@cvm.fda.gov.
SUPPLEMENTARY INFORMATION: In FR Doc. 03-17262, published on July 9,
2003 (68 FR 40984), the following correction is made:
1. On page 40984, in the first column, in the title,
``Clindamycin'' is corrected to read ``Bacitracin; Lasalocid; Narasin;
Roxarsone''.
In FR Doc. 03-17438, published on July 10, 2003 (68 FR 41161), the
following corrections are made:
1. On page 41161, in the third column, in the title, ``Bacitracin;
Lasalocid; Narasin; Roxarsone'' is corrected to read ``Clindamycin'';
and
2. On page 41161, in the third column, in the second paragraph of
the SUPPLEMENTARY INFORMATION section, the address for Delmarva
Laboratories, Inc., is corrected to read ``1500 Huguenot Rd., suite
106, Midlothian, VA 23113''.
Dated: September 15, 2003.
Linda Tollefson,
Deputy Director, Center for Veterinary Medicine.
[FR Doc. 03-24158 Filed 9-22-03; 8:45 am]
BILLING CODE 4160-01-S